Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 0 | 246 | 331 | 91 | 577 |
| Gross Profit | N/A | 246 | 331 | 91 | 577 |
| Operating Expenses | 162,267 | 103,086 | 118,590 | 105,905 | 31,564 |
| Operating Income | -162,267 | -102,840 | -118,259 | -105,814 | -30,987 |
| Interest Expense | 0 | 0 | 37 | 0 | 7 |
| Other Income | 7,141 | 4,006 | 2,935 | 1,023 | 304 |
| Pre-tax Income | -155,126 | -98,834 | -115,361 | -104,792 | -30,690 |
| Income Tax | 2 | -1,061 | 1,066 | 2 | 2 |
| Net Income Continuous | -155,127 | -97,773 | -116,426 | -104,793 | -30,692 |
| Net Income | $-155,127 | $-97,773 | $-116,426 | $-104,793 | $-30,692 |
| EPS Basic Total Ops | -2.84 | -2.12 | -2.69 | -2.91 | -1.07 |
| EPS Basic Continuous Ops | -2.84 | -2.12 | -2.69 | -2.91 | -1.07 |
| EPS Diluted Total Ops | -2.84 | -2.12 | -2.69 | -2.91 | -1.07 |
| EPS Diluted Continuous Ops | -2.84 | -2.12 | -2.69 | -2.91 | -1.07 |
| EPS Diluted Before Non-Recurring Items | -2.84 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-162,841 | $-102,196 | $-117,518 | $-104,962 | $-30,664 |